You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2025

List of Excipients in API cimetidine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing cimetidine hydrochloride

Detailed excipient profiles for cimetidine hydrochloride

Excipient focus: ALCOHOL

Excipient focus: FD&C RED NO. 40

cimetidine hydrochloride drug variants not containing FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

cimetidine hydrochloride drug variants containing FD&C YELLOW NO. 6

Excipient focus: HYDROCHLORIC ACID

cimetidine hydrochloride drug variants containing HYDROCHLORIC ACID

Excipient focus: MENTHOL

cimetidine hydrochloride drug variants not containing MENTHOL

Excipient focus: METHYLPARABEN

cimetidine hydrochloride drug variants containing METHYLPARABEN

Excipient focus: ORANGE

Excipient focus: POLOXAMER 188

Excipient focus: PROPYLENE GLYCOL

cimetidine hydrochloride drug variants containing PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

cimetidine hydrochloride drug variants containing PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

cimetidine hydrochloride drug variants containing SACCHARIN SODIUM

Excipient focus: SODIUM CHLORIDE

cimetidine hydrochloride drug variants containing SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE

cimetidine hydrochloride drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

cimetidine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Excipient focus: SORBITOL

cimetidine hydrochloride drug variants containing SORBITOL

Excipient focus: SORBITOL SOLUTION

cimetidine hydrochloride drug variants not containing SORBITOL SOLUTION

Excipient focus: WATER

cimetidine hydrochloride drug variants containing WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group